555win cung cấp cho bạn một cách thuận tiện, an toàn và đáng tin cậy [merck germany chemicals]
29 thg 7, 2025 · Merck’s (NYSE: MRK) Q2 2025 sales performance reflects strength across oncology and animal health, as well as increasing contributions from new launches. Our …
Merck aspires to be the premier research-intensive biopharmaceutical company in the world. Learn about our commitment to save and improve lives.
9 thg 6, 2025 · Merck has a long history of developing treatments for cardiovascular disease. More than 60 years ago, we introduced our first cardiovascular therapy—and our scientific …
3 thg 12, 2024 · Merck is rapidly advancing the global clinical development program evaluating sac-TMT as a monotherapy and in combination with KEYTRUDA ® (pembrolizumab) with 10 …
29 thg 7, 2025 · At Merck & Co., Inc., Rahway, N.J., USA, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge …
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Merck aspires to be the premier research-intensive biopharmaceutical company in the world. Learn about our commitment to save and improve lives.
25 thg 3, 2025 · Merck Enters Exclusive License Agreement for HRS-5346, an Investigational Oral Lipoprotein (a) Inhibitor, for Cardiovascular Disease from Jiangsu Hengrui …
12 thg 8, 2025 · Merck previously entered a clinical collaboration agreement with Seagen and Astellas to evaluate the combination of Merck’s KEYTRUDA ® (pembrolizumab) and Seagen’s …
22 thg 7, 2025 · At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve …
Bài viết được đề xuất: